Hospital Sierrallana

Torrelavega 39300

0 studies enrolling now · 3 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, COPD, Emphysema, Psoriatic Arthritis, Rheumatoid Arthritis

Studies at this site

• A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. — Completed
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis — Stopped early
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed